Skip to main content

roche-logo

The Medicines Co on Wednesday said it will receive up to $132 million in U.S. government funding for development of new antibiotics to fight drug-resistant infections, seen by health officials as a critically important need.

{iframe}http://www.reuters.com/article/usa-pharmaceuticals-medicines-idUSL2N1BV1RV{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.